Affiliation:
1. MBBS, Government Medical College, Aurangabad, Maharashtra; DNB (Obstetrics & Gynaecology), Ispat General Hospital, Rourkela, Odisha; Junior consultant in Cocoon Hospital, Jaipur, Rajasthan.
Abstract
Background: Pre-eclampsia affects about 5-10% of all pregnancies and is a major cause of maternal,
fetal and neonatal morbidity and mortality, particularly in developing countries. FOGSI and other
studies show the incidence of pre eclampsia in India ranges between 11-13%. Lactate Dehydrogenase (LDH) is mainly an
intracellular enzyme. LDH is present in many body tissues, especially heart, liver, kidney, skeletal muscle, brain, blood cells
and lungs. Its level is increased in the scenario of increased cell injury, hemolysis and cell death. Cellular enzymes in the
extracellular space although of no further metabolic function in this space, are still of benet because they serve as indicators
suggestive of disturbance of cellular integrity induced by pathological conditions and is used to detect cell damage or cell
death.This can be further used as help in making decision, regarding the management strategies to improve the maternal and
foetal outcome.
Objectives: To compare serum LDH levels in the normal pregnant women and in women with preeclampsia and eclampsia in
ante-partum period and to correlate the severity of the disease, maternal and perinatal outcome with Lactic Dehydrogenase
(LDH) levels in serum in patients of pre-eclampsia and eclampsia.
Material and Methods: A prospective comparative study was conducted in the department of Obstetrics and Gynaecology,
Ispat General Hospital, Rourkela. Out of 150 women studied, 50 were normal pregnant women, 32 were of mild preeclampsia,
35 were of severe preeclampsia and 33 of eclampsia. The statistical analysis was done by Chi-square test, Fischer Exact test,
analysis of variance and student ''t'' test (two tailed and independent).
Results: LDH levels were signicantly elevated in women with preeclampsia and eclampsia (p value <0.001). LDH levels had
signicant direct correlation with increasing blood pressure (p value <0.001) as well as poor maternal and perinatal outcome.
Conclusion: High serum LDH levels correlate well with the severity of the disease and poor maternal and fetal outcomes in
patients of preeclampsia and eclampsia and can be considered as a supportive biochemical and prognostic marker from early
third trimester.
Reference17 articles.
1. James PR, Nelson- Piercy C. Management of Hypertension before,during and after pregnancy. Heart. 2004;90:1499-1504
2. Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med J. 2003 December; 67:161.
3. Jaiswar S.P., Gupta A, Sachan R, Natu S.N, Shaili M. Lactic Dehydrogenase:A biochemical marker for preeclampsia-eclampsia. JOGI. 2011 Nov-Dec; 61(6):645-8.
4. Sarkar PD, Sogani S. Evaluation of serum lactate dehydrogenase and gamma glutamyltransferase in preeclamptic pregnancy and its comparison with normal pregnancy in third trimester. Int J Res Med Sci. 2013 [cited 2015 November 30]; 1(4): 365-8.
5. Munde SM, Hazari NR, Thorat AP, et al. Gamma GlutamylTransferase and Lactate Dehydrogenase as Biochemical Markers of Severity of Preeclampsia. International Journal of Medical, Health, Pharmaceutical and Biomedical Engineering .2014 ;8(1)